{"url":"https://investor-2017.hatenablog.com/entry/2019/12/21/070000","author_url":"https://blog.hatena.ne.jp/koto-x/","type":"rich","blog_url":"https://investor-2017.hatenablog.com/","categories":["\u7c73\u56fd\u682a"],"html":"<iframe src=\"https://hatenablog-parts.com/embed?url=https%3A%2F%2Finvestor-2017.hatenablog.com%2Fentry%2F2019%2F12%2F21%2F070000\" title=\"\u7c73\u56fd\u682a Neurocrine Biosciences (NASDAQ: NBIX)\u306b\u6295\u8cc7\u5b9f\u884c (6) - \u30a2\u30a4\u30c7\u30a2\u6295\u8cc7\u5bb6\u3000\u8cc7\u7523\u904b\u7528\u3068\u751f\u6d3b\u4e00\u5de5\u592b\" class=\"embed-card embed-blogcard\" scrolling=\"no\" frameborder=\"0\" style=\"display: block; width: 100%; height: 190px; max-width: 500px; margin: 10px 0px;\"></iframe>","author_name":"koto-x","published":"2019-12-21 07:00:00","width":"100%","image_url":"https://cdn-ak.f.st-hatena.com/images/fotolife/k/koto-x/20180111/20180111022203.jpg","version":"1.0","description":"\u524d\u56de\u306b\u7d9a\u304d\u3001\u795e\u7d4c\u7cfb\u3084\u5185\u5206\u6ccc\u7cfb\u306e\u75c5\u6c17\u3078\u306e\u88fd\u85ac\u958b\u767a\u3092\u3059\u308bNeurocrine Biosciences <NASDAQ: NBIX>\u3078\u306e\u6295\u8cc7\u306b\u81f3\u3063\u305f\u6295\u8cc7\u30b5\u30fc\u30d3\u30b9Motley\u306e\u63a8\u5968\u7406\u7531\u3092\u8907\u6570\u56de\u306b\u5206\u3051\u3066\u7d39\u4ecb\u3059\u308b\u3002 \u30fbNeurocrine Biosciences \u7d39\u4ecb\u8a18\u4e8b www.investor-2018.com www.investor-2018.com www.investor-2018.com www.investor-2018.com www.investor-2018.com \u305d\u308c\u3067\u306f\u30d0\u30a4\u30aa\u88fd\u85ac\u306e\u7814\u7a76\u958b\u767a\u3059\u308bNeurocrine Biosciences\u3092\u7d39\u4ecb\u3059\u308b\u3002 \u30fb\u30ea\u30b9\u30af\u3068\u58f2\u308a\u6642 Neuro\u2026","title":"\u7c73\u56fd\u682a Neurocrine Biosciences (NASDAQ: NBIX)\u306b\u6295\u8cc7\u5b9f\u884c (6)","provider_name":"Hatena Blog","height":"190","provider_url":"https://hatena.blog","blog_title":"\u30a2\u30a4\u30c7\u30a2\u6295\u8cc7\u5bb6\u3000\u8cc7\u7523\u904b\u7528\u3068\u751f\u6d3b\u4e00\u5de5\u592b"}